Back to all Companies

Dyania Health, Inc

Visit Website
Healthcare & Life SciencesPharmaceuticals, Diagnostics & Life Sciences
2019
Year Founded
2022
Year Selected
New York, US / Athens, Greece
Location(s)
21-50
Team Size

THE MISSION

Deliver top-tier, physician-guided AI solutions for healthcare, to dramatically expedite clinical research and provide access for patients in need today to the therapies of tomorrow.

Dyania Health is a venture-backed company founded in 2019 which has developed Synapsis AI, an end-to-end system that combines a medically pre-adapted LLM with a physician-driven algorithmic reasoning engine to understand and assess clinical characteristics in electronic medical records. Synapsis AI is designed for installation within the healthcare system's computing environment or on healthcare system private clouds to automate the process of manual chart review of EMRs, without removing any data from the healthcare system. Synapsis AI completes pre-screening on both unstructured and structured patient data, and deploys medical logic with temporal sensitivity to match dynamically changing patient characteristics with complex clinical trial criteria during the exact window of time that a given EMR may qualify for study protocol criteria.

OUR TAKE

Dyania Health is disrupting and transforming the way companies and research organizations leverage unstructured data that can create immense clinical value. The Dyania Health team has a combined over 800 academic publications and 120 years of experience in clinical research, drug development, and clinical technologies with backgrounds across top-tier organizations including Morgan Stanley and Amazon.

Program


investor logo
ScaleUp Program

Relevant Resources

See All

Endeavor ScaleUp 5th batch: 13 most promising high-growth companies that lead the way

Nov 10, 2022
Blog